Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
06 07 2021
Historique:
pubmed: 3 7 2021
medline: 30 10 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

Background As screening programs in low- and middle-income countries (LMICs) often do not have the resources to screen the entire population, there is frequently a need to target such efforts to easily identifiable priority groups. This study aimed to determine (1) how hypertension prevalence in LMICs varies by age, sex, body mass index, and smoking status, and (2) the ability of different combinations of these variables to accurately predict hypertension. Methods and Results We analyzed individual-level, nationally representative data from 1 170 629 participants in 56 LMICs, of whom 220 636 (18.8%) had hypertension. Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or reporting to be taking blood pressure-lowering medication. The shape of the positive association of hypertension with age and body mass index varied across world regions. We used logistic regression and random forest models to compute the area under the receiver operating characteristic curve in each country for different combinations of age, body mass index, sex, and smoking status. The area under the receiver operating characteristic curve for the model with all 4 predictors ranged from 0.64 to 0.85 between countries, with a country-level mean of 0.76 across LMICs globally. The mean absolute increase in the area under the receiver operating characteristic curve from the model including only age to the model including all 4 predictors was 0.05. Conclusions Adding body mass index, sex, and smoking status to age led to only a minor increase in the ability to distinguish between adults with and without hypertension compared with using age alone. Hypertension screening programs in LMICs could use age as the primary variable to target their efforts.

Identifiants

pubmed: 34212779
doi: 10.1161/JAHA.121.021063
pmc: PMC8403275
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e021063

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States

Références

Blood Press Monit. 1996 Feb;1(1):55-61
pubmed: 10226203
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Nutrients. 2020 Dec 23;13(1):
pubmed: 33374524
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
JAMA Intern Med. 2018 Mar 1;178(3):363-372
pubmed: 29379964
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Vasc Health Risk Manag. 2011;7:709-17
pubmed: 22174581
Med Biol Eng Comput. 2011 Jul;49(7):719-22
pubmed: 21597999
Vasc Health Risk Manag. 2007;3(4):389-400
pubmed: 17969368
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Circulation. 2012 May 8;125(18):2204-2211
pubmed: 22492580
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
PLoS One. 2019 Aug 19;14(8):e0215045
pubmed: 31425568
Blood Press Monit. 2003 Jun;8(3):127-33
pubmed: 12900590
Diabetes Care. 2012 Dec;35(12):2650-64
pubmed: 23100048
J Hum Hypertens. 2000 Jul;14(7):423-7
pubmed: 10918546
Hypertension. 2019 Apr;73(4):770-776
pubmed: 30739534
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
Ann Intern Med. 2015 Feb 3;162(3):184-91
pubmed: 25531552
BMC Cardiovasc Disord. 2016 Jan 13;16:9
pubmed: 26758197
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
Arq Bras Cardiol. 2009 Jan;92(1):10-5
pubmed: 19219259
Blood Press Monit. 2009 Jun;14(3):132-5
pubmed: 19433979
PLoS One. 2015 Jun 10;10(6):e0130218
pubmed: 26061419
BMC Bioinformatics. 2017 Mar 14;18(1):169
pubmed: 28292263
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Lancet Glob Health. 2019 Oct;7(10):e1332-e1345
pubmed: 31488387
Blood Press Monit. 2000 Aug;5(4):227-31
pubmed: 11035865
Int Health. 2015 Jul;7(4):262-5
pubmed: 25525132
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Blood Press Monit. 2006 Jun;11(3):165-71
pubmed: 16702826
Hypertension. 2013 Jul;62(1):18-26
pubmed: 23670299
J Am Heart Assoc. 2021 Jul 6;10(13):e021063
pubmed: 34212779

Auteurs

Tabea K Kirschbaum (TK)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Michaela Theilmann (M)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Nikkil Sudharsanan (N)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Jennifer Manne-Goehler (J)

Division of Infectious Diseases Massachusetts General HospitalHarvard Medical School Boston MA.

Julia M Lemp (JM)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Jan-Walter De Neve (JW)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.

Maja E Marcus (ME)

Department of Economics and Centre for Modern Indian Studies University of Goettingen Germany.

Cara Ebert (C)

RWI-Leibniz Institute for Economic Research Berlin Germany.

Simiao Chen (S)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Krishna K Aryal (KK)

Monitoring Evaluation and Operational Research Project Abt Associates Kathmandu Nepal.

Silver K Bahendeka (SK)

Saint Francis Hospital, Nsambya Kampala Uganda.

Bolormaa Norov (B)

National Center for Public Health Ulaanbaatar Mongolia.

Albertino Damasceno (A)

Faculty of Medicine Eduardo Mondlane University Maputo Mozambique.

Maria Dorobantu (M)

Cardiology Department Emergency Hospital of Bucharest Romania.

Farshad Farzadfar (F)

Non-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.

Nima Fattahi (N)

Non-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.

Mongal S Gurung (MS)

Health Research and Epidemiology Unit Policy and Planning Division Ministry of Health Thimphu Bhutan.

David Guwatudde (D)

Department of Epidemiology and Biostatistics School of Public Health Makerere University Kampala Uganda.

Demetre Labadarios (D)

Faculty of Medicine and Health Sciences Stellenbosch University Stellenbosch South Africa.

Nuno Lunet (N)

Departamento de Ciências da Saúde Pública e Forenses e Educação Médica Faculdade de Medicina da Universidade do Porto Porto Portugal.

Elham Rayzan (E)

Non-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.

Sahar Saeedi Moghaddam (S)

Endocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran.

Jacqui Webster (J)

The George Institute for Global HealthUniversity of New South Wales Sydney Australia.

Justine I Davies (JI)

Institute of Applied Health Research University of Birmingham United Kingdom.
Centre for Global Surgery Department of Global Health Stellenbosch University Cape Town South Africa.
Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit Faculty of Health Sciences School of Public Health University of the Witwatersrand Johannesburg South Africa.

Rifat Atun (R)

Department of Global Health and Population Harvard T.H. Chan School of Public Health Boston MA.

Sebastian Vollmer (S)

Department of Economics and Centre for Modern Indian Studies University of Goettingen Germany.

Till Bärnighausen (T)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Lindsay M Jaacks (LM)

Department of Global Health and Population Harvard T.H. Chan School of Public Health Boston MA.
Public Health Foundation of India New Delhi India.
Global Academy of Agriculture and Food Security The University of Edinburgh Midlothian United Kingdom.

Pascal Geldsetzer (P)

Heidelberg Institute of Global Health Medical Faculty and University Hospital University of Heidelberg Germany.
Division of Primary Care and Population Health Department of Medicine Stanford University Stanford CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH